| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXP | Common Stock | Award | $0 | +1.61K | +6.47% | $0.00 | 26.4K | May 8, 2023 | Direct | F1 |
| holding | EXP | Common Stock | 1.95K | May 8, 2023 | By 401(k) |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXP | Non-Qualified Stock Option (Right to Buy) | Award | $0 | +1.39K | $0.00 | 1.39K | May 8, 2023 | Common Stock | 1.39K | $126.22 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | On May 19, 2022, the reporting person was granted 1,605 shares of restricted stock, subject to the achievement by the Company of performance vesting criteria based on the Company's average return on equity measured at the end of fiscal 2023. On May 8, 2023 the performance vesting criteria was determined to have been met such that 1,605 shares of restricted stock became earned and reportable on such date. The restrictions on the earned shares will lapse ratably on May 17, 2023 and March 31 of 2024, 2025 and 2026. |
| F2 | In accordance with the issuer's Amended and Restated Incentive Plan, this price represents the closing price per share of Common Stock on the grant date. |
| F3 | On May 19, 2022, the reporting person was granted an option to purchase up to 1,391 shares of Common Stock, subject to the achievement by the company of performance vesting criteria based on the Company's average return on equity measured at the end of fiscal 2023. On May 8, 2023 the performance vesting criteria was determined to have been met such that 1,391 options became earned and reportable on such date. The earned options become vested and exercisable ratably on May 8, 2023 and March 31 of 2024, 2025 and 2026. |